Neurol. praxi. 2018;19(6):411-416 | DOI: 10.36290/neu.2018.130

Language and behavioral disturbance in primary progressive aphasia

doc. MUDr. Robert Rusina, Ph.D.1,2, prof. PaedDr. Zsolt Cséfalvay, PhD.1,3
1 Neurologická klinika a Centrum klinických neurověd, 1. LF UK a VFN, Praha
2 Neurologické oddělení, Thomayerova nemocnice, Praha
3 Katedra logopedie, Komenského Univerzita, Bratislava

Primary progressive aphasias (PPA) are neurodegenerative diseases with isolated language impairment and later progression intodementia. PPA include three clinical subtypes with different clinical manifestation and underlying neuropathology. The nonfluent/agrammatic variant has the lowest language production with apraxia of speech and mostly belongs to tauopathies; the hallmarkof the semantic variant is a progressive loss of the meanings of words resulting in severe impairment of language comprehension,the underlying cause is mostly a TDP-43 proteinopathy; and the logopenic variant is typically manifesting with reducedsentence repetition and anomia, often due to Alzheimer’s disease. Behavioral manifestations in PPA typically include agitation,eating abnormalities, disinhibition and irritability, often associated with apathy. Early recognition of behavioral disturbances inPPA, adequate supportive and pharmacological treatment and concise caregiver support are prerequisites for preventing bothinstitutionalization of patients and excessive caregiver burden.

Keywords: primary progressive aphasia, speech therapy, disinhibiton, irritability, focal atrophy, tauopathy, TDP-43 proteinopathy,
Alzheimer’s disease

Published: December 10, 2018  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Rusina R, Cséfalvay Z. Language and behavioral disturbance in primary progressive aphasia. Neurol. praxi. 2018;19(6):411-416. doi: 10.36290/neu.2018.130.
Download citation

References

  1. Agosta F, Galantucci S, Valsasina P, Canu E, Meani A, Marcone A, Magnani G, Falini A, Comi G, Filippi M. Disrupted brain connectome in semantic variant of primary progressive aphasia. Neurobiol Aging 2014; 35: 2646-2655. Go to original source... Go to PubMed...
  2. Banks SJ, Weintraub S. Neuropsychiatric symptoms in behavioural variant frontotemporal dementia and primary progressive aphasia. J Geriatr Psychiatry Neurol 2008; 21: 133-141. Go to original source... Go to PubMed...
  3. Bardoň J, Nevrly? M, Kan?ovsky? P, Otruba P, Čecháčková M, Večermová M, Baláž M. Prima?rni? progresivni? apraxie r?ec?i. Neurol. praxi 2017; 18: 64-66. Go to original source...
  4. D'Anna L, Mesulam MM, Thiebaut de Schotten M, Dell'Acqua F, Murphy D, Wieneke C, Martersteck A, Cobia D, Rogalski E, Catani M. Frontotemporal networks and behavioral symptoms in primary progressive aphasia. Neurology 2016; 86: 1393-1399. Go to original source... Go to PubMed...
  5. Finney GR, Heilman KM. Artwork before and after onset of progressive nonfluent aphasia. Cogn Behav Neurol 2007; 20: 7-10. Go to original source... Go to PubMed...
  6. Galantucci S, Tartaglia MC, Wilson SM, Henry ML, Filippi M, Agosta F, Dronkers NF, Henry RG, Ogar JM, Miller BL, Gorno-Tempini ML. White matter damage in primary progressive aphasias: a diffusion tensor tractography study. Brain 2011; 134: 3011-3029. Go to original source... Go to PubMed...
  7. Gorno-Tempini ML, Dronkers NF, Rankin KP, Rankin KP, Ogar JM, Phengrasamy L, Rosen HJ, Johnson JK, Weiner MW, Miller BL. Cognition and anatomy in three variants of primary progressive aphasia. Ann Neurol 2004; 55: 335-346. Go to original source... Go to PubMed...
  8. Gorno-Tempini ML, Hillis AE, Weintraub S, Kertesz A, Mendez M, Cappa SF, Ogar JM, Rohrer JD, Black S, Boeve BF, Manes F, Dronkers NF, Vandenberghe R, Rascovsky K, Patterson K, Miller BL, Knopman DS, Hodges JR, Mesulam MM, Grossman M. Classification of primary progressive aphasia and its variants. Neurology 2011; 76: 1006-1014. Go to original source... Go to PubMed...
  9. Grossman M. The non-fluent/agrammatic variant of primary progressive aphasia. Lancet Neurol 2012; 11: 545-555. Go to original source... Go to PubMed...
  10. Hurley RS, Paller KA, Rogalski EJ, Mesulam MM. Neural mechanisms of object naming and word comprehension in primary progressive aphasia. J Neurosci 2012; 32: 4848-4855. Go to original source... Go to PubMed...
  11. Josephs KA, Duffy JR, Strand EA, Whitwell JL, Layton KF, Parisi JE, Hauser MF, Witte RJ, Boeve BF, Knopman DS, Dickson DW, Jack CR Jr, Petersen RC. Clinicopathological and imaging correlates of progressive aphasia and apraxia of speech. Brain 2006; 129: 1385-1398. Go to original source... Go to PubMed...
  12. Josephs KA, Duffy JF, Strand EA, Machulda MM, Senjem ML, Master AV, Lowe VJ, Jack CR Jr, Whitwell JL. Characterizing a neurodegenerative syndrome: primary progressive apraxia of speech. Brain 2012; 135: 1522-1536. Go to original source... Go to PubMed...
  13. Josephs KA, Duffy JR, Strand EA, Machulda MM, Senjem ML, Lowe VJ, Jack CR, Whitwell JL. Syndromes dominated by apraxia of speech show distinct characteristics from agrammatic PPA. Neurology 2013; 81: 337-345. Go to original source... Go to PubMed...
  14. Midorikawa A, Kumfor F, Leyton CE, Foxe D, Landin-Romero R, Hodges JR, Piguet O. Characterisation of "positive" behaviours in primary progressive aphasia. Dement Geriatr Cogn Disord 2017; 44: 119-128. Go to original source... Go to PubMed...
  15. Menšíková K, Tučková L, Kaňovský P. Atypický parkinsonizmus a frontotemporální demence - klinické, patologické a genetické aspekty. Cesk Slov Neurol N 2016; 79/112: 275-286. Go to original source...
  16. Mesulam M-M, Wieneke C, Thompson C, Rogalski E, Weintraub S. Quantitative classification of primary progressive aphasia at early and mild impairment stages. Brain 2012; 135:1537-1553. Go to original source... Go to PubMed...
  17. Multani N, Galantucci S, Wilson SM, Shany-Ur T Poorzand P, Growdon ME, Jang JY, Kramer JH, Miller BL, Rankin KP, Gorno-Tempini ML, Tartaglia MC. Emotion detection deficits and changes in personality traits linked to loss of white matter integrity in primary progressive aphasia. Neuroimage Clin 2017; 16: 447-454. Go to original source... Go to PubMed...
  18. Modirrousta M, Price BH, Dickerson BC. Neuropsychiatric symptoms in primary progressive aphasia: phenomenology, pathophysiology, and approach to assessment and treatment. Neurodegener Dis Manag 2013; 3:133-146. Go to original source... Go to PubMed...
  19. Montembeault M, Brambati SM, Gorno-Tempini ML, Migliaccio R. Clinical, anatomical, and pathological features in the three variants of primary progressive aphasia: a review. Front Neurol 2018; 9: 692. doi: 10.3389/fneur.2018.00692.eCollection 2018 Go to original source... Go to PubMed...
  20. Park MH, Kim EJ, Park KW, Kwon JC, Ku BD, Han SH, Kim S, Yang DW, Na DL, Choi SH. Behavioural and neuropsychiatric disturbance in three clinical subtypes of frontotemporal dementia: A Clinical Research Center for Dementia of South Korea-FTD Study. Australas J Ageing 2017; 36: 46-51. Go to original source... Go to PubMed...
  21. Rosen HJ, Allison SC, Ogar JM, Amici S, Rose K, Dronkers N, Miller BL, Gorno-Tempini ML. Behavioral features in semantic dementia vs other forms of progressive aphasias. Neurology 2006; 67: 1752-1756. Go to original source... Go to PubMed...
  22. Rusina R, Cséfalvay Zs. Progresivní afázie. In: Rusina R, Matěj R a kol. Neurodegenerativní onemocnění. Praha: Mladá fronta 2014, 133-141.
  23. Seeley WW, Bauer AM, Miller BL, Gorno-Tempini ML, Kramer JH, Weiner M, Rosen HJ. The natural history of temporal variant frontotemporal dementia. Neurology 2005; 64: 1384-1390. Go to original source... Go to PubMed...
  24. Singh TD, Duffy JR, Strand EA, Machulda MM, Whitwell JL, Josephs KA. Neuropsychiatric symptoms in primary progressive aphasia and apraxia of speech. Dement Geriatr Cogn Disord 2015; 39: 228-238. Go to original source... Go to PubMed...
  25. Tippett DC, Thompson CB, Demsky C, Sebastian R, Wright A, Hillis AE. Differentiating between subtypes of primary progressive aphasia and mild cognitive impairment on a modified version of the Frontal Behavioral Inventory. PLoS One 2017 Aug 16; 12: e0183212. Go to original source...




Neurology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.